Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.4M Buy
35,555
+35,053
+6,983% +$15M ﹤0.01% 833
2025
Q4
$215K Sell
502
-27,145
-98% -$11.8M ﹤0.01% 1741
2025
Q3
$12M Buy
27,647
+19,602
+244% +$8.88M ﹤0.01% 827
2025
Q2
$3.79M Sell
8,045
-22,782
-74% -$13M ﹤0.01% 973
2025
Q1
$19.1M Sell
30,827
-6,963
-18% -$3.96M 0.01% 716
2024
Q4
$20.1M Sell
37,790
-11,340
-23% -$6.39M 0.01% 716
2024
Q3
$28.9M Sell
49,130
-17,230
-26% -$9.77M 0.01% 648
2024
Q2
$35.8M Buy
66,360
+62,155
+1,478% +$35.6M 0.01% 599
2024
Q1
$2.51M Buy
4,205
+189
+5% +$115K ﹤0.01% 1104
2023
Q4
$2.31M Sell
4,016
-796
-17% -$445K ﹤0.01% 1157
2023
Q3
$2.42M Buy
4,812
+1,849
+62% +$961K ﹤0.01% 1128
2023
Q2
$1.6M Sell
2,963
-5,934
-67% -$3.24M ﹤0.01% 1206
2023
Q1
$4.89M Buy
8,897
+1,151
+15% +$587K ﹤0.01% 999
2022
Q4
$3.82M Buy
7,746
+7,741
+154,820% +$3.77M ﹤0.01% 1059
2022
Q3
$2K Buy
+5
New +$2.4K ﹤0.01% 1820
2021
Q3
Sell
-156
Closed -$74K 1573
2021
Q2
$74K Buy
+156
New +$74.9K ﹤0.01% 1465

Other funds holding CHE

Amundi's CHE Position: Q1 2026 in Review

Amundi increased its Chemed (CHE) stake by 6,983% in Q1 2026, buying an estimated $15M and bringing the position to 35,555 shares worth $13.4M. The position accounts for ﹤0.01% of the portfolio, ranked #833.

Amundi first reported a position in CHE in Q2 2021 and has held it in 16 quarters since. The position peaked at $35.8M in Q2 2024. 488 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • Amundi held 35,555 shares of Chemed worth $13.4M as of Q1 2026.
  • Amundi bought 35,053 Chemed shares in Q1 2026, an estimated $15M.
  • Chemed made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #833 holding.
  • Amundi first reported a position in Chemed in Q2 2021 and has held it in 16 quarters since.
  • Amundi's Chemed position peaked at $35.8M in Q2 2024.
  • 488 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.